IL-20 in rheumatoid arthritis

研究成果: Review article同行評審

6 引文 斯高帕斯(Scopus)

摘要

Rheumatoid arthritis, a systemic autoimmune disease, causes chronic joint inflammation and bone destruction. Interleukin (IL)-20's association with this disease, and its expression and regulation has been extensively studied since 2006. Anti-IL-20 antibody has paved the way to clinical trials aimed at blocking the pathogenic actions of IL-20 in rheumatoid arthritis. This review focuses on current knowledge of IL-20's involvement in the pathogenesis of rheumatoid arthritis.

原文English
頁(從 - 到)960-964
頁數5
期刊Drug Discovery Today
22
發行號6
DOIs
出版狀態Published - 2017 六月

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

指紋 深入研究「IL-20 in rheumatoid arthritis」主題。共同形成了獨特的指紋。

引用此